Manufacturing

  1. Breaking Down Shipping 11/13/2023

    Here, Umoja's Co-Founder and CTO Ryan Crisman and BMS’ Global Head, Cell Therapy Logistics and Shipping Systems, Rookie Gleich talk about whether temperature monitoring devices are really truly necessary when using a shipper that has been tested and validated to hold a specific temperature range for a specified period, and more.

  2. Cell Therapy's Current Manufacturing Challenges 4/15/2025

    In this segment, Cell & Gene’s Chief Editor, Erin Harris, welcomes the audience and introduces the expert panelists, Rohit Ingale, Head of Manufacturing & MSAT, Arcellx and David O’Donnell, Vice President, Head of Manufacturing, Vor Bio.

  3. CTS DynaCellect Cinematic Overview 6/2/2025

    Achieve high cell purity and recovery with an automated, closed magnetic separation system. Learn how this technology helps increase robustness, minimize failures, and streamline cell therapy manufacturing.

  4. Advances In Custom Medium Development: The Multi-Omics Difference 6/9/2025

    Spent media analysis continues to be an essential part of many media development workflows. Newer techniques, however, using state-of-the-art analytical technology, are becoming more popular.

  5. Early Development Choices Define Scalability And Product Quality In CGT 10/29/2025

    In this segment of Cell & Gene Live, Designing Early Manufacturing For Long-Term Success In CGT, Raymond Luke, Senior Director of MSAT at Verismo Therapeutics and Todd Luman, Executive Director of Process and Product Development at Allogene stress that early-stage process decisions have lasting downstream effects on product quality, scalability, and speed to clinic.

  6. True Innovations In Driving Down Cell Therapy Manufacturing 2/26/2021

    In this webinar segment, Dr. Mark Gilbert, Thomas Lequertier, and Luděk Sojka talk through the innovations in the manufacturing processes for both autologous and allogeneic therapies.

  7. MilliporeSigma Bio-Expo Live February 2025: Upstream Bioprocessing 3/18/2025

    Review the benefits of implementing a closed and sterile sampling system, such as NovaSeptum®, to improve sampling procedures and meet regulatory expectations.

  8. How MacroGenics Increased mAb Titers By Up To 80% In Scale-Up 4/16/2026

    Learn how a structured, scalable approach to process development can help improve productivity, maintain product quality, and support a smoother transition to manufacturing.

  9. Emerging Manufacturing Technologies For Cell Therapies | Audience Q&A 4/15/2025

    Cell & Gene Live’s Audience Q&A always draws valuable questions in real time from our audience. Rohit Ingale, Head of Manufacturing & MSAT, Arcellx and David O’Donnell, Vice President, Head of Manufacturing, Vor Bio provide detailed responses to audience questions that addressed the importance of vein-to-vein time for non-cancer indications, such as autoimmune diseases.

  10. Simplifying Bioprocess Data Collection 2/17/2023

    Centralized bioprocess data collection and aggregation lowers the risk of data loss during any manual retrieval process. Discover a solution that helps you meet data storage and reporting requirements.